Clinical trial

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

NCT04151940

Study summary

ClinicalTrials.gov

PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer

Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

7 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

PROCEDURE · Unmapped registry intervention Positron Emission Tomography Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Computed Tomography Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Chemotherapy Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Immunotherapy Find medicine records · Find other trials using this name

RADIATION · Unmapped registry intervention Radiation Therapy Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Biospecimen Collection Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention Magnetic Resonance Imaging Find medicine records · Find other trials using this name

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2019-09-26

PhaseNA

Conditions

Metastatic Lung Non-Small Cell Carcinomaunresolved

Recurrent Lung Non-Small Cell Carcinomaunresolved

Stage IV Lung Cancer AJCC v8unresolved

Interventions

Positron Emission TomographyPROCEDURE

Computed TomographyPROCEDURE

ChemotherapyDRUG

ImmunotherapyBIOLOGICAL

Radiation TherapyRADIATION

Biospecimen CollectionPROCEDURE

Magnetic Resonance ImagingPROCEDURE

Sponsors & collaborators

University of Washingtonlead sponsor

National Cancer Institute (NCI)collaborator

Mapped research locations

SeattleWashington, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04151940 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.